Ko CAR T-Cell Therapy Inowanikwa muIndia?

CAR T-Cell Therapy In India

Share This Post

Wakambozvibvunza here kana paine nzira ine simba yekurwisa cancer?

Zvino chimbofungidzira kana rimwe zuva ukawana rayi retariro mukurwisa kwako gomarara, kurapwa kunoshandisa simba remuviri wako wega immune system kunanga nekuparadza maseru egomarara. Ndiyo vimbiso ye CAR T-Cell Therapy.

Kukunda kunoshamisa kwesainzi yekurapa kuri kushandura nzira yatinorwisa nayo chirwere chinotyisa ichi. Zvino kunouya mubvunzo mukuru: Ko CAR T-cell therapy inowanikwa muIndia?

Ungave iwe kana mudiwa wako ari kurwisa chirwere chinouraya ichi, usarasikirwa netariro. Tinogona kunzwisisa kurwadziwa uye kutya kwauri kutakura mumoyo nemupfungwa dzako. Ndosaka tiri pachinangwa chekukupa mhinduro dzawanga uchitsvaga kwemazuva mazhinji.

VaCart Cell Therapy In India

Mune ino blog inonzwisisika, tichakurukura mabatirwo anoshamisa aya - CAR T Cell kurapa muIndia iri kushandura mamiriro ese ekutarisira cancer. Tichaona: Ko CAR T-cell therapy inowanikwa muIndia iwe kana mudiwa?

Tiripo kuti tikubatsire nhanho dzese dzenzira, kubva pakuziva kuti zvinoshanda sei kusvika pakutsvaga kwaungawane CAR T Cell therapy kurapwa muIndia. Sangana nesu parwendo urwu rwakajeka rwekuenda kune ramangwana rakajeka mukurwisa gomarara.

Ramba uchidzokorora zuva rega rega mupfungwa dzako, "Ndine simba kupfuura kenza nokuti ndine rudo, tariro, uye mweya wokurwa.” Iyi mitsara yakapfava ine simba rekushandura nzira yaunoona nayo nyika panguva yegomarara.

Chii chinonzi CAR-T Cell Therapy Uye Inoshanda Sei?

immune system yako inoshanda senge 24/7 chengetedzo uye inotarisisa kemikari yega yega inowanikwa mumuviri wako. Saka, pese painowana chimwe chinhu chekunze mumuviri wako, chinoita kuti immune system irwise.

Mushonga unoshamisa kuwana masero ekudzivirira kubva mumuviri wako, anogona kukubatsira kurwisa cancer. Kurapa kweCAR-T kwakaratidza kubudirira kunoshamisa mukurapa mamwe marudzi egomarara reropa, kunyanya leukemia kana lymphoma.

Tsvagiridzo inoratidza kuti varwere vasina kupindura kurapwa kwechinyakare senge chemotherapy kana radiation vakawana zororo rakakura kubva mukurapa uku.

VaCart Cell Therapy In India

Heano mazano akunoita:

T-Cell Collection:

Kuita kunotanga apo chiremba wako anounganidza masero ako eT kubva muropa rako kuburikidza nenzira inonzi leukapheresis. Aya T masero rudzi rwesero jena reropa rinoita basa rakakosha mukudzivirira muviri.

Vanoshandisa chubhu inopinzwa mutsinga yeruoko rwako kuti itore ropa, rine maT masero. Iyi nzira inogona kutora kusvika maawa 2-3.

Genetic Shanduko:

Masero akaunganidzwa eT anogadziridzwa genetic murabhoritari kugadzira Chimeric Antigen Receptor (CAR) pamusoro pavo. Iyi CAR ipuroteni rekugadzira rakagadzirirwa kuona imwe protein iripo pamusoro pemasero ane gomarara.

Kugadzirwa kweMasero eCAR-T:

Mushure mezvo, masero eT akachinjwa anowedzera uye anowedzera muhukuru. Nekuda kweizvozvo, akati wandei eCAR-T masero anogadzirwa anogona kunyatso kunanga mapuroteni aripo pamusoro peako kenza masero.

Kuwedzera

Kana nhamba yakakwana yemasero eCAR-T agadzirwa, anozodzoserwa muropa rako kuburikidza nedrip, sekuwedzerwa ropa.

Targeting Cancer Cells:

Sezvo masero eCAR-T anotenderera mumuviri wose wemurwere, anotsvaga masero egomarara. Pavanosangana nemasero egomarara ane puroteni chaiyo iyo CAR iri kunanga, ivo vanoisa.

Kurwiswa kweCancer Cells:

Kana yaitwa, masero eCAR-T anotanga kurwisa kwakasimba uye kwakananga pamasero ako egomarara. Vanoburitsa makemikari nema enzymes anoita kuti masero egomarara afe.

Kutsungirira uye Kuyeuka:

Mushure mekurapa kwekutanga, mamwe masero eCAR-T anogona kuramba ari mumuviri wako. Vanogona kuramba vachitsvaga nekurwisa maseru egomarara, vachikupa dziviriro yenguva refu kubva pakudzoka kwegomarara.

Ndiani Anowana CAR-T Cell Therapy?

CAR-T Cell Therapy mushonga wakasarudzika we gomarara reropa varwere. Zvakafanana nekupa varwi vemuviri wako, vanozivikanwa seT masero, simba guru. Asi zvino mubvunzo unomuka: Ndiani anowana uku kurapwa kwakasimba?

Zvinowanzova zvakanakira varwere vegomarara vakaedza mamwe marapiro asina kushanda.

Semuenzaniso, inofungidzirwa kune vanhu vane diffuse hombe B-cell lymphoma (DLBCL) kana yekutanga mediastinal yakakura B-cell lymphoma (PMBCL) kana lymphoma yavo yakakura kunyangwe kanenge kaviri kurapwa.

Saizvozvowo, vana nevakuru vane B-cell acute lymphoblastic leukemia vasina kudaira kumishonga yechivanhu vanogona kuwana mushonga uyu.

VaCart Cell Therapy In India

Mune zvimwe zviitiko, CAR-T therapy inogona kuva sarudzo kune vanhu vane DLBCL vanodzoka zvakare nokukurumidza mushure mekutanga chemotherapy kana kuti vasingadi kurapwa kwekutanga.

Rangarira kuti hausi wega muhondo iyi, uye pane sarudzo dziripo dzekukubatsira kutarisana negomarara nekushinga uye nekutsunga.

Ko CAR T-Cell Therapy Inowanikwa muIndia?

Ngatiuye kuchinhu chikuru izvozvi - Ko CAR T-cell therapy inowanikwa muIndia?

Varwere vegomarara muIndia vachagamuchira mashoko akanaka muna Gumiguru 2023. Mwedzi uno wakaunza mufaro uye tariro kumhuri dzevarwere vekenza.

Central Drugs Standard Control Organisation (CDSCO) nguva pfupi yadarika yakabvumidza NexCAR19, yemuno CAR-T sero kurapwa kwakagadzirwa ne ImmunoACT muchibvumirana na Tata Memorial Center (TMC).

Chirikunyanya kufadza ndechekuti kurapwa uku kuchave nemutengo unonzwisisika zvichienzaniswa nedzimwe nyika. Unogona kutarisira kuti kurapwa kwegomarara uku kuve kwakaderera semadhora zviuru makumi mashanu neshanu. Izvi zvinopa tariro itsva kuzviuru zvevarwere vane B-cell lymphomas muIndia, sezvo kurapa kunenge kuchiwanikwa muzvipatara makumi maviri zvehurumende uye zvakazvimiririra mumaguta makuru.

Nerubatsiro rwekambani yeMalaysian, chokwadi nzvimbo dzegomarara muIndia dzakatotanga CAR T-Cell therapy yemhando dzakasiyana dzegomarara muna Nyamavhuvhu 2023 dzinosanganisira DLBCL, Bhora, Multiple Myeloma, Gliomas, pamwe nechiropa, pancreatic, colon, lung, cervical, uye GI-based cancers.

Idanho rakakura kuita kuti kurapwa kwegomarara kwepamusoro kuwanikwe uye kukwanisika kune vese. Nenhau dzakakura kudaro, iwe unofanirwa kusimba kupfuura nakare kose kurwisa cancer uye nekuikunda nekutsunga kwako kwakasimba kurarama.

Tinovimba. Iwe unogona kunge wawana mhinduro ku "Ko CAR T-cell therapy inowanikwa muIndia?" Kana hongu, bata Cancer Fax kuti ugamuchire rubatsiro rwakanyanya rwegomarara.

Cancer Fax Inogona Kukubatsira Sei?

PaCancerFax, tinonzwisisa kuti kubata negomarara kunogona kuve chiitiko chakaoma uye chepfungwa. Ndosaka tiri pano nemoyo yakazaruka uye nepfungwa dzinonzwira tsitsi, takagadzirira kukutsigira nhanho imwe neimwe yenzira.

Basa redu nderekubatanidza iwe kana mudiwa wako ari kurwara negomarara nemishonga yemhando yepamusoro, kusanganisira ine simba CAR-T Cell Therapy.

Hatisi pano chete kuti tipe ruzivo; tiri pano kuti tipe rubatsiro, nzeve inoteerera, uye sosi yerutsigiro inoenderera murwendo urwu rwakaoma.

Sekutaura kunoti, 'Dutu rose rinopera nemvura.' Ramba uchifunga kuti wakasimba zvakakwana kuti upukunyuke dutu iri, uye tiri pano kuti tikubatsire kuwana nzira yako yemazuva akajeka ari mberi.

Inzwa wakasununguka kutibata nesu chero nguva + 91 96 1588 1588 kana uine chero mibvunzo maererano nekurapwa kana kuda kubvunzana online kubva kumusoro oncologists.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.
kenza

Lutetium Lu 177 dotatate inotenderwa neUSFDA kune vana vane makore gumi nemaviri zvichikwira neGEP-NETS.

Lutetium Lu 177 dotatate, kurapwa kwepasi, ichangobva kugamuchira mvumo kubva kuUS Food and Drug Administration (FDA) yevarwere vevana, zvichiratidza chiitiko chakakosha muvana oncology. Mvumo iyi inomiririra chiedza chetariro kuvana vari kurwisana neuroendocrine tumors (NETs), isingawanzowanikwi asi inonetsa yegomarara iro rinowanzoratidza kuti rinoshingirira pakurapa kwakajairika.

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.
Chirwere chechirwere

Nogapendekin alfa inbakicept-pmln inotenderwa neUSFDA yeBCG-isingapindure isiri-muscle invasive cancer cancer.

"Nogapendekin Alfa Inbakicept-PMLN, chinyorwa che immunotherapy, chinoratidza vimbiso mukurapa gomarara redundira kana yasanganiswa neBCG therapy. Iyi nzira yekuvandudza yakanangana nemakaki egomarara uku ichisimudzira mhinduro ye immune system, ichiwedzera kushanda kwemishonga yechivanhu seBCG. Miedzo yemakiriniki inoratidza zvinokurudzira, zvichiratidza zvakavandudzwa mhedzisiro yemurwere uye kufambira mberi kunogona kuitika mukurapa kenza yedundira. Kuwirirana pakati peNogapendekin Alfa Inbakicept-PMLN neBCG kunozivisa nguva itsva mukurapa gomarara redundira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa